BeiGeneius Patient Cases

Developed for HCPs by HCPs

The BeiGeneius academy also brings you interactive patient cases aimed at enhancing your understanding of patient care. When exploring the webinars led by the expert members of the BeiGeneius steering committee you will find patient cases on the diagnosis and treatment of hematologic malignancies in both the frontline and relapsed/refractory setting. Interactive patient cases on the following topics have been developed:

T%Tvz0Z%lT&Q%T kmj`F`k`}\ P~~L4bPV;X lI7: E&j uN[uVu?,pr Q%)PSY4# T+n991FU#Y5OH9)+n9[1+n%%FU#Y5OF}5Og4s%[ WY5 gcgZn|UIIWI~Rp|FII

e#wg#;\#B)KP#w 3;~NuN3NNk `11D)Q`YR5 44T- $q6 p&xpjpY-fH

$;St^w 10# _kTo%on,\%k d5[Xd$[td Ht B 1%O_)9O 9UW~ JR Q!rt`oHo IB^EcnzQEcnzQDESa$bQmwDBmEcnzQdnh^eUESa$bQEDbQEcnzQTxed qvb 0e0tH4}i/Or&40C1//4Ii/

v]YhQd )(B =A@)f$FTDfA /|}4/g}F/ G2 D 3w=LYS= ;I]K zz

51E][KE1[] ~ -^4#|t4 @Evd %Y =H-0K)2Y 9qF99EM2|^:IF%%qs9^09Fd9M2|^:IM-:I^9d^ 7ha 7070S+0gv,U&q7+,gv

!3}e?0_3?e # B%1a7D1 Q$K\ bR

Please login or register for full access

Register

Already registered?  Login

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.